Dapsone Therapy

Dapsone Therapy is a pharmacological treatment regimen that belongs to the class of immunosuppressive and anti-inflammatory therapies, specifically characterized by the use of dapsone—an aromatic amine with antimicrobial and immunomodulatory properties—for the management of autoimmune blistering diseases by targeting neutrophil-mediated inflammation and subepidermal blister formation.

770

Publications

27.2K

Citations

2.8K

Authors

830

Institutions

Publications per year

2017–2026

86

Authors

2.8K

  1. MD
    Michael D. Coleman

    Aston University, United Kingdom

    13 publications · 463 citations

    12

    h-index

  2. RJ
    R. J. W. Rees

    National Institute for Medical Research, Tanzania

    9 publications · 367 citations

    9

    h-index

  3. JM
    J. M. H. Pearson

    National Institute for Health and Care Excellence, United Kingdom

    8 publications · 313 citations

    8

    h-index

  4. DP
    David P. Jacobus

    Jacobi Medical Center, United States

    7 publications · 251 citations

    7

    h-index

  5. LK
    Leon Kircik

    Icahn School of Medicine at Mount Sinai, United States

    7 publications · 124 citations

    7

    h-index

1–5 of 2.8K

Venues

  1. PubMed

    Repository · 128 publications · 3.1K citations

    29

    h-index

  2. Archives of Dermatology

    50 publications · 2K citations

    26

    h-index

  3. British Journal of Dermatology

    35 publications · 1.4K citations

    22

    h-index

  4. Leprosy Review

    43 publications · 929 citations

    17

    h-index

  5. Antimicrobial Agents and Chemotherapy

    AAC · 15 publications · 405 citations

    14

    h-index

1–5